Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Walgreens Boots Alliance Inc (WBA) USD0.01

Sell:$47.56 Buy:$48.07 Change: $0.34 (0.70%)
Market closed |  Prices as at close on 26 February 2021 | Switch to live prices |
Change: $0.34 (0.70%)
Market closed |  Prices as at close on 26 February 2021 | Switch to live prices |
Change: $0.34 (0.70%)
Market closed |  Prices as at close on 26 February 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Walgreens Boots Alliance, Inc., is a holding company. The Company is a pharmacy-led health and wellbeing company. The Company operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy services. The Retail Pharmacy International segment consists primarily of the Alliance Boots pharmacy-led health and beauty stores, optical practices and related contract manufacturing operations. The Pharmaceutical Wholesale segment consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. The Company's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as global health and beauty product brands, including No7, Botanics, Liz Earle and Soap & Glory.

Contact details

108 Wilmot Rd
United States
+1 (847) 3152500

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$42.48 billion
Shares in issue:
864.04 million
Drug Retail
United States
US dollar

Key personnel

  • James Skinner
    Executive Chairman of the Board
  • Stefano Pessina
    Executive Vice Chairman of the Board, Chief Executive Officer
  • James Kehoe
    Global Chief Financial Officer, Executive Vice President
  • Ornella Barra
    Co-Chief Operating Officer
  • Alexander Gourlay
    Co-Chief Operating Officer
  • Pamela Puryear
    Global Chief Human Resource Officer, Executive Vice President
  • Marco Pagni
    Executive Vice President, Chief Administrative Officer, General Counsel
  • John Standley
    Executive Vice President, President - Walgreens
  • Heather Dixon
    Senior Vice President, Chief Accounting Officer, Global Controller
  • Francesco Tinto
    Senior Vice President, Global Chief Information Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.